Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.
about
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Fertility sparing treatment in borderline ovarian tumoursNovel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancerOncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study.Port-site metastasis of mucinous borderline ovarian tumor after laparoscopyEpithelial borderline ovarian tumor: Diagnosis and treatment strategy.Mucinous Borderline Ovarian Tumor in Very Old Aged Postmenopausal WomanExternal multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.Borderline tumours of the ovary, current controversies regarding their diagnosis and treatmentManagement of borderline ovarian tumours: a comprehensive review of the literature.Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.Fertility preservation in women with borderline ovarian tumors- how does it impact disease outcome? A cohort study.Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.Pelvic recurrence of an ovarian seromucinous borderline tumor detected by vaginal cytology: A case report and review of the literature.Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study.Fascin-1 expression as stratification marker in borderline epithelial tumours of the ovary.Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.New Pointers for Surgical Staging of Borderline Ovarian Tumors.The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.The value of fine needle aspiration cytology diagnosis in ovarian masses in children and adolescents.Atypical ovarian calcifications associated with bilateral borderline ovarian tumors.Assessing the risk of clinical and pathologic factors for relapse of borderline ovarian tumours.The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors.TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary.
P2860
Q26852127-B1E4569C-B0E2-4562-B158-D0D184C23ECDQ28081482-CE8E960A-8626-4C8E-8122-5A9A843760BEQ30818695-4EF1E126-B53D-4D1C-BB66-950793C001FFQ33711871-8E264B9D-C7C9-4680-B559-B95C24150E5CQ33872622-466DE124-5DFC-4D83-A09A-852C1D3B5623Q34317865-1A87FE85-5DE3-4130-9953-0574AA1E1E1BQ34546250-2E47E7A8-A9C7-411E-AFF7-1D570B6B89CAQ34792049-ED70C7B7-07FA-4EC9-A013-9B2B9CE52700Q35649353-7999E3B2-A79A-406B-98F7-0CD0E21B7F81Q36480479-AD451469-7CEE-4BC1-9011-BADE027300C4Q37352621-8FA744C3-6F85-4EC0-B55F-73883DC03DA6Q37376449-B8A64BEA-B04A-4A95-9910-63D775001A9AQ37406768-B31C97DB-0A78-484C-B524-17BF97FC5CB2Q37597335-D76A0162-BA54-4130-BC27-BDE1A0EC8159Q38167276-238E0812-78B9-44D7-862F-7F96EDBCCCECQ38195137-9FFA4BC0-C12D-4F88-9904-285EB17D51D3Q38203062-7294DAC7-4515-4CB3-9A1D-369A83226CC9Q38620963-4998A938-5143-48F6-87CF-6D01AA239BBDQ38679731-9D77E7A1-3FE2-4CED-B634-5DE8FE48CDD7Q38681393-E5EC8A91-C0C7-4039-BA56-8CA9B75CC25FQ38887201-EFB28BB7-564F-439D-AC0D-07A7C0BA6C33Q40364793-03009FCF-79C0-4E7D-8610-32E98384EC85Q40547169-81184EA5-F63C-43A3-8F7C-1768A4DDE0DDQ40633138-15B18668-4F4A-411B-A5A5-D38A4EE1CBFBQ41255506-A22E3187-1B1C-46E9-9BC8-69CBA6C7576FQ41721833-DA7C8952-2608-4CD7-A40A-B667DE138833Q43944256-D66F632F-4656-4465-BD25-C14A41FD86B0Q44503886-DA0431AA-B627-49A8-962C-7BB48E7180CCQ47614431-801197A7-BA01-452C-9EB7-154C016EEE9CQ49569127-5005634F-2803-4540-91A2-23DFFC657849Q51021273-24458D2F-632B-43D2-88A7-BA0047DBBCEEQ55184151-90581FD3-F2D0-4A32-9DDB-B85DB089C666
P2860
Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@en
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@nl
type
label
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@en
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@nl
prefLabel
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@en
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@nl
P2093
P1433
P1476
Borderline ovarian tumour: pat ...... invasive or lethal recurrence.
@en
P2093
Catherine Uzan
Philippe Morice
Pierre Duvillard
Raffaele Fauvet
Sebastien Gouy
P304
P356
10.1016/S1470-2045(11)70288-1
P50
P577
2012-03-01T00:00:00Z